Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
References Traber MG
This patient was identified to have a presumed de novo variant of COL3A1 p.Glu1171Lys and was published in 2015 by Frank et al
10.1111/imr.13235 40 TianP.XuZ.GuoJ.ZhaoJ.ChenW.HuangW.et al (2024)
Niu X, Wang C, Li H, Chen W
Furthermore, coagulation disorders, present in COVID-19 patients, increase neuroinflammation, stroke, and cognitive decline risks (Pezzini and Padovani 2020)
Neurochem Res 37:27062714 Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P, Alzheimer's Disease Cooperative S (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
US$ 22.61
US$ 21.80
US$ 21.29
US$ 22.37
